Postpartum Depression

3 articles published between August 30, 2026 and September 9, 2026.

WHAT THE STUDY ACTUALLY SAYS

Zuranolone is the first oral drug for postpartum depression. What the trial showed

In the SKYLARK trial, a 14-day course improved depression scores faster than placebo. The effect was real but modest, and the label carries a driving-impairment warning.

3 min read

ANALYSIS

Two perinatal sleep studies, one gap: nobody is asking the question

13% of women met criteria for insomnia disorder six weeks after delivery, and only two had been evaluated. In a separate cohort, restless legs in pregnancy tripled the risk of perinatal depression.

4 min read

WHAT THE STUDY ACTUALLY SAYS

Traumatic birth ranged from 7% to 69% across 31 countries in one survey

The INTERSECT study asked 11,302 women 6 to 12 weeks postpartum about birth trauma. The spread between countries is far wider than the average, and that is the finding.

3 min read

This page indexes this newspaper’s reporting on Postpartum Depression. It is not a medical reference entry, and nothing here is medical advice. See our editorial standards.